Article may be outdated

This article is 5 days old. Some details may have changed since publication.

TRT Afrika·3 min read·hard

Guinea Bissau seizes doses of baby vaccines linked to controversial US study

Guinea Bissau seizes doses of baby vaccines linked to controversial US study
✦AI Summary

Police in Guinea-Bissau have seized a batch of hepatitis B vaccines from a US-funded project that the WHO previously labeled as unethical. The investigation aims to protect public health while authorities review the circumstances surrounding the controversial trial.

Why it matters

The seizure underscores the tension between international research initiatives and local health oversight in developing nations.

✦Dive DeeperCreate a free account to unlock

Police in Guinea-Bissau have seized a batch of vaccines from a facility affiliated with a stalled, US-funded hepatitis B immunisation trial on newborn babies that the WHO has slammed as "unethical".The study, which would randomise whether or not 14,000 newborns in the highly impoverished west African nation receive a hepatitis B vaccine birth dose,was suspended pending further technical review, the WHO said in February.The Guinea-Bissau judicial police said that on Monday they carried out a "seizure of a batch of hepatitis B vaccines intended for the immunisation of children in the country".The vaccines were confiscated at the Bandim Health Project, which is led by Danish researchers in charge of the hepatitis B testing.The Danish researchers' previous work has looked into alleged vaccine harms, and their methods have come under scrutiny by the scientific community.‘Proven safety records’The US Centers for Disease Control and Prevention had awarded a $1.6 million grant for…

Continue reading on Headlinne

Create a free account to read the full article.

Read full article →
healthworldscience
✦

Get smarter about the news

Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.

Create free account

Already have an account? Sign in